BI
BioAge Labs, Inc. (BIOA)
NASDAQ·Healthcare·Biotechnology
$19.86
-3.49%
Mkt Cap $679.20M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$43.75
Range $23.00 – $62.00
Implied Upside
+120.3%
Consensus $43.75 vs current $19.86
NASDAQ·Healthcare·Biotechnology
$19.86
-3.49%
Mkt Cap $679.20M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$43.75
Range $23.00 – $62.00
+120.3%
Consensus $43.75 vs current $19.86